ATAI - Company ID 0001840904
ATAI Life Sciences N.V. trades as ATAI and has a market capitalization of $1.88 B, making it the #2194 largest US-listed company by market value. This page tracks ATAI Life Sciences N.V. through 320 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-11
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Net profit margin compressed from -823.6% to -48464.0% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider sale notice | 144 | 2026-03-20 |
| Insider sale notice | 144 | 2026-02-26 |
| 15-12G | - | 2025-12-31 |
| POSASR | - | 2025-12-31 |
| S-8 POS | - | 2025-12-31 |
| Major company event | 8-K | 2025-12-05 |
| 424B7 | - | 2025-12-05 |
| Insider trade | 4 | 2025-11-26 |
AtaiBeckley Launches Patient Impact Grant Program for Mental Health Non-Profit Organizations | AtaiBeckley Inc.
AtaiBeckley to Participate in Upcoming Investor Conferences in June 2026 | AtaiBeckley Inc.
AtaiBeckley Reports First Quarter 2026 Financial Results and Provides Program and Business Update | AtaiBeckley Inc.
AtaiBeckley and PsyPAN Receive a Silver Award in 2026 Patient Participant Index, Reflecting Ongoing Commitment to Participant-Informed Research | AtaiBeckley Inc.
AtaiBeckley Announces Additional Phase 2a Results for EMP-01 (oral R-MDMA) Showing Large and Consistent Improvements in Social Anxiety Disorder | AtaiBeckley Inc.
The largest companies sharing ATAI Life Sciences N.V.'s SEC industry classification (pharmaceutical preparations).
ATAI Life Sciences N.V. (ATAI) has a market capitalization of $1.88 B as of 2026-07-11, ranking #2194 among US-listed companies.